[-] Show simple item record

dc.contributor.authorRotert, Eric M.eng
dc.contributor.authorBasarich, John R.eng
dc.contributor.authorNashelsky, Joaneng
dc.date.issued2005-06eng
dc.description.abstractPatients with a first episode of calf DVT with a transient risk factor should receive heparin therapy followed by oral anti- coagulation for six to 12 weeks. [Strength of recommendation: A, based on systematic review of randomized controlled trials (RCTs)] If anticoagulation is contra-indicated, physicians should monitor for proximal thrombus extension with duplex ultrasound twice weekly for two weeks. [Strength of recommendation: C, based on consensus guideline]eng
dc.identifier.citationAmerican Family Physician, 71(11) 2005.eng
dc.identifier.urihttp://hdl.handle.net/10355/3962eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2005 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectthrombus extensioneng
dc.subjectpulmonary embolismeng
dc.subjectlow-molecular-weight heparin (LMWH)eng
dc.subject.lcshPulmonary embolismeng
dc.subject.lcshThrombophlebitis.eng
dc.subject.lcshHeparin -- Therapeutic useeng
dc.titleTreatment of Calf Deep Venous Thrombosiseng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record